oncolytic virus

Daiichi Sankyo claims first okay for oncolytic virus in Japan

https://pharmaphorum.com/news/daiichi-sankyo-claims-first-okay-for-cancer-killing-virus-in-japan/

Sillajen explains Pexa-Vec trial failure – it was the rescue meds

https://pharmaphorum.com/news/sillajen-explains-pexa-vec-trial-failure-it-was-the-rescue-meds/

Immunotherapy arms race latest: Merck buys Viralytics for $394m

https://pharmaphorum.com/news/merck-co-buy-viralytics-cancer-killing-virus-394m/

Close in 10 seconds

Pharmaphorum.com

Search